Optimizing Daptomycin Dosing: Environmental Benefit and Cost Savings
Antimicrobial Stewardship & Healthcare Epidemiology · 2025-07 · 5 (S2) · s4-s4
DOI: 10.1017/ash.2025.193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 24.09.2025. Verfasst von Pamela Lee und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The pharmaceutical industry is estimated to have a larger environmental footprint than the automotive industry. Discarded and unused doses of pharmaceuticals generate financial waste and pollution, and exacerbate antibiotic shortages. The antibiotic daptomycin is dispensed in standard-sized single-use vials and dosed based on patient weight. Residual daptomycin in the vial after dose preparation must be disposed of and cannot be used for another patient. We hypothesized that daptomycin dosing nomogram use would reduce daptomycin waste, environmental impact, and financial costs.
Methods
We performed a retrospective chart review quantifying daptomycin waste, defined as disposed of unused daptomycin, at Harbor-UCLA Medical Center, a 400-bed Level 1 Trauma Center, from 1/1/2023 to 12/31/2023. We then adjusted dosing using a daptomycin dosing nomogram. We modeled the difference in daptomycin waste (mg of daptomycin disposed of unused), pharmaceutical waste (weight of excess daptomycin vials required due to wasted antibiotic), and cost between the two dosing strategies. Our model assumed a daptomycin vial weight of 16.8g and cost of $30 per 500mg daptomycin vial. We conservatively estimated pharmaceutical waste as waste only from daptomycin vials, ignoring all other supplies and materials necessary to prepare daptomycin.
Results
During the 1 year time period at our Medical Center, 138,882mg daptomycin was wasted. This level of daptomycin waste equates 4671g excess pharmaceutical waste and $8332 spent on unused, discarded daptomycin. In our model, we found that nomogram implementation would have reduced mean monthly daptomycin waste from 11,002mg to 1387mg (p
Zitieren
APA
Lee, P., Nguyen, M., LeBrun, M., Fong, G., & Miller, L. (2025). Optimizing Daptomycin Dosing: Environmental Benefit and Cost Savings. Antimicrobial Stewardship & Healthcare Epidemiology, 5(S2), s4-s4. https://doi.org/10.1017/ash.2025.193
Vancouver
Lee P, Nguyen M, LeBrun M, Fong G, Miller L. Optimizing Daptomycin Dosing: Environmental Benefit and Cost Savings. Antimicrobial Stewardship & Healthcare Epidemiology. 2025;5(S2):s4-s4. doi:10.1017/ash.2025.193
BibTeX
@article{Lee2025,
author = {Lee, Pamela and Nguyen, Marina and LeBrun, Michelle and Fong, Gary and Miller, Loren},
title = {Optimizing Daptomycin Dosing: Environmental Benefit and Cost Savings},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2025},
volume = {5},
number = {S2},
pages = {s4--s4},
doi = {10.1017/ash.2025.193}
}
EUVIMED